Maria Shoshans forskargrupp

Mer information finns på den engelska sidan.


Maria Shoshan, PhD, docent
Nicole Bezuidenhout, doktorand

Utvalda publikationer

PGC1α: Friend or Foe in Cancer?
Mastropasqua F, Girolimetti G, Shoshan M
Genes (Basel) 2018 Jan;9(1):

On mitochondrial metabolism in tumor biology.
Shoshan M
Curr Opin Oncol 2017 01;29(1):48-54

Metabolic profiling of epithelial ovarian cancer cell lines: evaluation of harvesting protocols for profiling using NMR spectroscopy.
Engskog M, Björklund M, Haglöf J, Arvidsson T, Shoshan M, Pettersson C
Bioanalysis 2015 ;7(2):157-66

Expression of mitochondrial regulators PGC1α and TFAM as putative markers of subtype and chemoresistance in epithelial ovarian carcinoma.
Gabrielson M, Björklund M, Carlson J, Shoshan M
PLoS ONE 2014 ;9(9):e107109

Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites.
Wintzell M, Hjerpe E, Åvall Lundqvist E, Shoshan M
BMC Cancer 2012 Aug;12():359

Repeated cisplatin treatment can lead to a multiresistant tumor cell population with stem cell features and sensitivity to 3-bromopyruvate.
Wintzell M, Löfstedt L, Johansson J, Pedersen AB, Fuxe J, Shoshan M
Cancer Biol. Ther. 2012 Dec;13(14):1454-62

Cisplatin-induced nitrosylation of p53 prevents its mitochondrial translocation.
Hernlund E, Kutuk O, Basaga H, Linder S, Panaretakis T, Shoshan M
Free Radic. Biol. Med. 2009 Jun;46(12):1607-13

Ovarian carcinoma cells with low levels of beta-F1-ATPase are sensitive to combined platinum and 2-deoxy-D-glucose treatment.
Hernlund E, Hjerpe E, Avall-Lundqvist E, Shoshan M
Mol. Cancer Ther. 2009 Jul;8(7):1916-23